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A B S T R A C T
Shiga toxin-producing Escherichia coli (STEC) cause gastrointestinal illnesses including non-bloody or bloody
diarrhoea, haemorrhagic colitis (HC), and the haemolytic uremic syndrome (HUS). To investigate the occurrence
of STEC among grazing dromedaries from Kenya, E. coli isolated from fecal matter collected from 163 dro-
medaries on a large ranch were screened for the presence of stx1 and stx2. STEC strains were isolated and
serotyped. Isolates were subjected to PCR for the subtyping of stx genes and for the detection of eae and ehx. In
addition, whole genome sequencing (WGS) was carried out to detect further virulence genes and to determine
the multilocus sequence types (MLST). Antimicrobial resistance proﬁles were determined by disk diﬀusion.
STEC was isolated from 20 (12.3%) of the fecal samples. Thereof, nine (45%) isolates were STEC O156:H25,
three (15%) isolates typed STEC O43:H2. The remaining isolates occurred as single serotypes or were O non-
typeable. Eleven (55%) of the isolates harboured stx2a, nine (45%) eae, and 14 (70%) ehx, respectively. WGS
revealed the presence of iss in 16 (80%), subAB in four (20%) and astA in two (10%) of the isolates, Furthermore,
espA, tccP, nleA, nleB, tccP, and tir were found exclusively among STEC O156:H25.
Eleven diﬀerent sequence types (ST) were detected. The most prominent was ST300/ST5343, which com-
prised STEC O156:H25. All STEC isolates were pan susceptible to a panel of 16 antimicrobial agents. Overall, the
results indicate that dromedary camels in Kenya may be reservoirs of STEC, including serotypes possessing
virulence markers associated to disease in humans, such as STEC O156:H25. STEC in camels may represent a
health hazard for humans with close contact to camels or to consumers of camel derived foodstuﬀs, such as
unpasteurised camel milk.
1. Introduction
In Eastern Africa, the one-humped Arabian camel (Camelus drome-
darius) is an important livestock species particularly well adapted to
semi-arid and arid environments [1]. In Kenya, the husbandry of semi-
domesticated dromedaries is a traditional livelihood of the nomadic
pastoralists, with milk constituting an important nutrient source and
income asset [2].
Kenya as a country relies heavily on wildlife tourism [3]. In the
Laikipia county in central Kenya which is known for its remarkable
abundance of wildlife, livestock husbandry and tourism are alternatives
to land cultivation [4,5]. Dromedary camel herds have become estab-
lished both in pastoral communities and on large ranches where they
are used for wildlife safaris and to produce milk for consumption and
trade [1].
Camels in sub-saharan Africa reportedly represent a reservoir for a
variety of potentially zoonotic diseases and pathogens, including
Coxiella burnetii [6], Brucella spp. [7], Hepatitis E Virus [8], and Middle
East respiratory syndrome coronavirus [9]. By contrast, Shiga toxin-
producing Escherichia coli (STEC), which may cause gastrointestinal
illnesses including non-bloody or bloody diarrhoea, haemorrhagic co-
litis (HC), and the haemolytic uremic syndrome (HUS) [10], has rarely
been described in camels. STEC causes an estimated 2,801,000 acute
illnesses annually and poses a signiﬁcant health burden worldwide
[11,12].
The distinguishing feature of STEC is the presence of one or more
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Shiga toxin (stx) genes which include two major forms, stx1 and stx2
and subtypes thereof [13]. Other major virulence genes that inﬂuence
the pathogenic potential of STEC include the intimin gene eae, and the
enterohemolysin gene ehx [14,15]. Additional virulence factors such as
espA, nleA, iss or subAB are also frequently associated with disease in
humans [16,17].
STEC O157:H7 is the serotype most frequently associated with se-
vere clinical outcomes, nonetheless, non-O157 STEC serogroups, in-
cluding O26, O103, O111, and O145, are also recognized for their
pathogenic potential [18].
Wild and domestic animals, including cattle, sheep, goats and deer
represent the most important reservoirs of STEC [12]. Examples of
healthy domestic animals that are known to be hosts of human patho-
genic STEC serotypes are given in Table 1. The consumption of con-
taminated water, meat, raw milk, raw milk products and produce, and
the direct contact with farm animals have been identiﬁed as important
routes of transmission [12,19]. A better understanding of the occur-
rence of STEC among animal reservoirs is essential to provide a fra-
mework for developing approaches to reduce the burden of STEC re-
lated disease worldwide.
So far, E. coli O157:H7 and STEC O157:H7 was isolated from meat
and feces of camels in Iran, respectively [20,21]. By contrast, several
studies have reported the absence of STEC in camels in the United Arab
Emirats and Eastern Africa [22–24].
This study aimed to update the current understanding on the oc-
currence of STEC in camels in Eastern Africa by screening fecal samples
of a herd of healthy animals kept under extensive husbandry systems on
a ranch in Laikipia, Kenya, and to characterize all STEC strains with
regard to their serotypes and their virulence potential.
2. Material and methods
2.1. Sample collection
Fecal samples of 163 healthy dromedary camels (117 females, 45
males and one of unknown gender) located in a ranch in the northern
Laikipia county in Kenya were collected during January and February
2017. The camels were extensively kept, they shared their pasture with
game and cattle. Fecal matter was collected by rectal palpation using
one glove per animal. Samples were placed in sterile containers, cooled
for transport and frozen at −80 °C.
The sample collection was performed in strict accordance with the
Kenyan legislation for animal experimentation and were approved by
the institutional animal care and use committee (IACUC reference
number 2014.08). Since 1993, the International Livestock Research
Institute (ILRI) in Kenya has complied voluntarily with the United
Kingdom's Animals (Scientiﬁc Procedures) Act 1986 that contains
guidelines and codes of practice for the housing and care of animals
used in scientiﬁc procedures.
2.2. Screening for stx by PCR
Each fecal sample was enriched at a 1:10 ratio in Enterobacteriaceae
enrichment (EE) broth (Becton, Dickinson, Heidelberg, Germany) for
24 h at 37 °C. One loopful of each of the enrichment cultures was cul-
tured on sheep blood agar (Difco™ Columbia Blood Agar Base EH;
Becton Dickinson AG, Allschwil, Switzerland) using the streak plate
technique. The resulting colonies were washed oﬀ with 2ml 0.85%
NaCl and DNA was extracted by a standard lysis protocol. Screening for
stx1 and stx2 genes was performed by real-time PCR (LightCycler R 2.0
Instrument, Roche Diagnostics Corporation, Indianapolis, IN, USA)
using the QuantiFast Multiplex PCR Kit (Qiagen, Hombrechtikon,
Switzerland) according to the guidelines of the European Union
Reference Laboratory (EURL) [25].
2.3. Recovery of STEC
In the event of a stx positive PCR result, one loopful each of the
enrichment broth was streaked onto on sheep blood agar (Difco™
Columbia Blood Agar Base EH; Becton Dickinson AG, Allschwil,
Switzerland) and onto RAPID'E. coli Agar (BioRad, Basel, Switzerland)
to obtain single colonies of E. coli.
From each plate, individual colonies were picked and suspended in
0.5 ml NaCl 0.85%. Isolates that were conﬁrmed to possess stx
(stx1and/or stx2) by real-time PCR were subcultured on sheep blood
agar and the presence of stx was conﬁrmed using the Assurance GDS®
for Shiga Toxin Genes (Bio Control Systems, Bellevue, WA, USA). From
plates yielding more than one stx positive colony, one isolate was
randomly chosen for subsequent characterization.
2.4. Serotyping and molecular typing of stx, eae and ehx genes
Isolates were serotyped using the E. coli SeroGenoTyping AS-1 Kit
(Alere Technologies, Jena, Germany). The determination of stx1 sub-
types (stx1a, stx1c, stx1d) and stx2 subtypes (stx2a, stx2b, stx2c, stx2d,
stx2e, stx2g) was performed by conventional PCR ampliﬁcation [13].
Screening for eae, and ehx was performed by real-time PCR according to
the guidelines of the EURL [26].
2.5. Whole genome sequencing
Genomic DNA libraries were prepared using the Nextera™ DNA Flex
Library Preparation Kit following the manufacturer's protocol
(Illumina, San Diego, CA, USA). Libraries were loaded on a 300-cycle,
2× 150 bp paired-end read cartridge (Illumina MiniSeq High Output
Reagent Kit) and run on a MiniSeq Illumina sequencer (Illumina). The
Spades assembler v3.12 [27] was used to assemble the reads with using
the option “—careful”. The spades output was ﬁltered for size> 1000
bp and coverage> 25-fold resulting in the ﬁnal assemblies that were
submitted to NCBI GenBank.
The sequence reads were used to run analysis in the Advanced
Research Infrastructure for Experimentation in genomics (ARIES)
public Galaxy server (https://w3.iss.it/site/aries/), i.e. quality control,
assembly, virulence gene analysis, Shiga-toxin analysis, and serotyping.
To assess the genetic relatedness of the isolates, core genome mul-
tilocus sequence typing (cgMLST) was carried out using Ridom Seq-
Sphere Software (version 4.1.9, available at http://www.ridom.de/
seqsphere/cgmlst/). The MLST schemes “Warwick” and “Pasteur” were
used for MLST-typing, and the Enterobase Escherichia/Shigella v1
scheme (http://enterobase.warwick.ac.uk) for cgMLST typing.
Assembled genomes were blasted against the reference database using
standard settings and the option “ignore missing values pairwise” and
“Discard genomes with> 3% missing genes” were used for typing.
Trees were visualised using the minimal spanning tree option in seq-
sphere.
Table 1
Examples of healthy (semi)-domestic animals as hosts of Shiga toxin-producing
Escherichia coli (STEC) serotypes associated with disease in humans.
Animal STEC serotype(s) Reference(s)
Camels O157:H7, O156:H25 [21], this study
Cattle O157:H7, O156:H25, O8:H19, O26:H2, O26:H8,
O26:H11, O26:H19, O26:H21, O45:H2, O103:H2,
O103:H21, O121:H8, O145:H2, O145:H8,
O145:H28, O146:H21
[29,36–40]
Chicken O157:H7 [36,37]
Goats O146:H21, O82:H8, O128:H2 [40–42]
Sheep O157:H7, O26:H11, O146:H21, O128:H2 [37,40,41,43]
Swine O157:H7 [36,37]
Turkeys O157:H7 [36]
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2.6. Antibiotic resistance proﬁles
Antimicrobial susceptibility testing was performed using the disk-
diﬀusion method and the antibiotics ampicillin (AM), amoxicillin-cla-
vulanic acid (AMC), cefazolin (CZ), cefotaxime (CTX), cefepime (FEP),
nalidixic acid (NA), ciproﬂoxacin (CIP), gentamicin (GM), kanamycin
(K), streptomycin (S), sulfamethoxazole/trimethoprim (SXT), fosfo-
mycin (FOS), azithromycin (AZM), nitrofurantoin (F/M), chlor-
amphenicol (C) and tetracycline (T) (Becton Dickinson, Heidelberg,
Germany). Results were interpreted according to Clinical and
Laboratory Standards Institute (CLSI) performance standards [28].
3. Results and discussion
In sub-Saharan Africa, little information is available on the epide-
miology of STEC in humans, food and animals, and current knowledge
of STEC sources needs to be improved [12]. Data on the occurrence and
the characteristics of STEC in African camels is limited. This study
provides evidence for the fecal carriage of STEC among dromedary
camels located on a ranch in Laikipia Kenya. The restriction to one farm
in Kenya is a limitation of this study and may have led to bias associated
with camels from one herd only. In order to obtain a wider picture,
analyses of feces from camels on other farms and other regions in Kenya
would be required. For this investigation, a total of 163 fecal swabs
were obtained. Thereof, 53 (32.5%) tested positive for stx by real-time
PCR. STEC was recovered from 20 of the stx positive samples,
amounting to 12.3% of all fecal samples. Overall, fecal carriage of STEC
was conﬁrmed for 14.5% (17 of a total of 117) of the female camels and
6.7% (3 of 45) of the male camels (Table 2).
The serotypes and virulence genotypes of the STEC isolates are
summarized in Table 2. The most frequent serotypes included nine
(45% of the isolates) STEC O156:H25 isolates and three (15%) O43:H2
isolates. The remaining strains occurred as single serotypes or were O
non-typeable (Table 2). STEC O156:H25 has been described as a per-
sistent colonizer of the bovine gut [29] and has also been linked to
human infection in Germany and Switzerland [30,31] (Table 1). By
contrast, STEC O43:H2 is a rare serotype, but has been detected in beef
in West Africa [32].
Further, various stx subtypes were detected among the isolates, in-
cluding stx2a which is associated with severe disease in STEC infected
humans [33]. The stx2a gene was found in a total of 11 (55%) of the
isolates, including the nine STEC O156:H25 strains, and the STEC
O8:H49 and STEC Ont:H7 isolates, respectively (Table 2). The intimin
gene eae was detected in nine (45%) isolates, all belonging to serotype
O156:H25 (Table 2). While eae is one of the most prominent virulence
factors contributing to pathogenesis, many STEC feature other viru-
lence genes that may enhance their pathogenic potential, such as en-
terohaemorrhagic E. coli haemolysin ehx [15,30]. In this study, ehx was
detected by PCR in fourteen (70%) of the isolates (Table 2).
Furthermore, we used WGS to provide additional information on the
virulence of the analysed STEC. Table 2 shows the presence or absence
of a selection of virulence genes that predict severe disease in humans,
including espA, tccP, nleA, nleB and tir (de Boer et al., [16]). Other
virulence factors included in Table 2 are iss, which encodes an increased
serum survival protein and is associated with non-bloody diarrhoea as
well as extra-intestinal pathogenic infections [34], subAB, which is an
emerging pathogenic factor among eae negative human pathogenic
STEC isolates [17], and astA encoding a heat-stable enterotoxin EAST1
that is found mostly in enterohaemorrhagic and enteroaggregative E.
coli [35]. The complete ARIES analysis reports on the virulotypes of the
20 sequenced strains are available upon request.
Taken together, espA, tccP, nleA, nleB and tir were detected ex-
clusively among the nine STEC O156:H25 isolates, while iss was iden-
tiﬁed in 16 (80%), and subAB in four (20%) of the isolates, respectively
(Table 2). A minority of two strains (10%) possessed astA (Table 2).
Although all STEC can conceivably cause diarrhoea, the risk and se-
verity of infection is linked to the presence of virulence factors, in
particular stx2a and eae [12]. Our results show that although 45% of
the STEC isolated from camel feces are not highly pathogenic according
to their virulence factor proﬁles, the majority (55%) is associated with
stx2a, and STEC O156:H25 isolates in particular, exhibit a virulotype
that suggests a potential health risk.
Using the Pasteur scheme, four diﬀerent sequence types (ST) were
identiﬁed among 14 isolates (Table 2). Using the Warwick scheme, 11
diﬀerent STs were identiﬁed (Table 2). Of the nine STEC O156:H25
isolates, eight grouped in the sequence type ST300 and ST5334, which
Table 2
Characteristics of Shiga toxin-producing Escherichia coli (STEC) isolated from feces of camels from Kenya.
Strain ID Host gender Serotype Virulence genes MLST GenBank accession no.
stx subtype eae ehx astA espA iss nleA nleB tccP tir subAB ST Warwick ST Pasteur
C59 F O8:H19 stx1a − + − − + − − − − − 201 294 RJDD00000000
C102 F O8:H49 stx2a − + − − + − − − − − 111 nd RJDT00000000
C139 F O43:H2 stx1c − − − − + − − − − − 937 363 RJDN00000000
C119 F O43:H2 stx1a − − − − + − − − − + 6275 363 RJDS00000000
C160 F O43:H2 stx1c − − − − + − − − − + 6275 363 RJDK00000000
C34 F O44:H18 stx1a, stx2c − + − − + − − − − + 6507 nd RJDG00000000
C21 F O117:H12 stx1a − − − − + − − − − − 101 nd RJDJ00000000
C22 F O150:H8 stx1c − + + − − − − − − + 906 303 RJDI00000000
C12 F O156:H25 stx2a + + − + + + + + − − 300 591 RJDR00000000
C15 F O156:H25 stx2a + + − + + + + − + − 300 591 RJDM00000000
C16 F O156:H25 stx2a + + − − − − − − − − 300 591 RJDL00000000
C25 F O156:H25 stx2a + + − + + + + + + − 300 591 RJDH00000000
C43 F O156:H25 stx2a + + − + − + + − + − 300 591 RJDF00000000
C62 F O156:H25 stx2a + + − + + + + − + − 300 591 RJDC00000000
C85 F O156:H25 stx2a + + − + + + + − + − 300 591 RJDB00000000
C129 M O156:H25 stx2a + + − + + + + − + − 300 591 RJDP00000000
C101 M O156:H25 stx2a + + + + + + + + + − 5343 591 RJDU00000000
C127 F Ont:H7 stx1a, stx2a − + − − − − − − − − 1308 nd RJDQ00000000
C56 M Ont:H20 stx1c − − − − + − − − − − 5759 nd RJDE00000000
C131 F Ont:H20 stx1c − − − − + − − − − − 5759 nd RJDO00000000
astA, gene encoding enteroaggregative heat-stable toxin; eae, intimin gene; ehx, enterohemolysin gene; espA, gene encoding LEE-associated secreted translocator
protein; F, female; iss, gene encoding increased serum survival protein; M, male; MLST, multilocus sequence type; nd, not deﬁned; nle, genes encoding non-LEE-
encoded factors; ST, sequence type; subAB, subtilase cytotoxin gene; tccP, gene encoding Tir cytoskeleton coupling protein; tir, gene encoding translocated intimin
receptor; +, the gene is present; −, the gene is absent.
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diﬀer by one nucleotide in the gyrB gene, indicating close phylogenetic
relationship of the isolates. Similarly, the three STEC O43:H2 isolates
were assigned to ST937 and ST6275 which diﬀer by one nucleotide in
fumC. Two STEC Ont:H20 possessed ST5759. All other isolates belonged
to singly occurring STs (Table 2). Accordingly, cgMLST using Ridom
SeqSphere+ software divided the strains into distinct clusters that
comprised the STEC O156:H25 isolates, the STEC O43:H2 isolates, and
the Ont:H20 isolates, respectively, while the remaining strains did not
reveal close phylogenetic relationship (Fig. 1).
Finally, all STEC isolates remained fully susceptible to all anti-
microbials tested (data not shown).
4. Conclusions
The data from our study suggest that dromedary camels are a re-
servoir of human pathogenic STEC. While none of the fecal samples
contained STEC O157:H7 or other non-O157 STEC serogroups fre-
quently associated with severe clinical outcomes such as bloody diar-
rhoea, HC, or HUS, the majority of the isolates harboured stx2a, and the
STEC O156:H25 isolates harboured eae, ehx, and other virulence factors
often associated with disease in humans. Their occurrence in fecal
samples from camels may represent a threat to humans, especially to
those who live in long-term close contact with camels and consume raw
camel milk.
Nucleotide sequences
The nucleotide sequences have been deposited at GenBank under
accession nos. RJDB00000000-RJBU00000000.
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